You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 119655


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 119655

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope and Claims and Patent Landscape for Argentina Patent AR119655

Last updated: August 2, 2025

Introduction

Patent AR119655, granted in Argentina, pertains to a pharmaceutical invention that likely covers a novel drug, formulation, or method of treatment. Analyzing the scope of claims and understanding the patent landscape surrounding this patent provides critical insights for stakeholders, including pharmaceutical companies, generic manufacturers, and legal professionals, to assess the patent's strength, potential for infringement, and strategic positioning within the Argentine and global markets.

This report offers a comprehensive dissection of AR119655’s claims, examines its technological scope, and contextualizes its standing within the broader patent landscape.


1. Patent Overview and Filing Context

AR119655 was filed to secure protection for a specific pharmaceutical innovation (details of which—such as active ingredients, administration methods, or formulations—would typically be outlined explicitly in the patent document). The Argentine Patent Office (INPI) granted it, indicating that the invention met criteria of novelty, inventive step, and industrial applicability.

The patent is likely filed by a pharmaceutical entity aiming to extend market exclusivity for a particular drug or novel treatment method. Argentina’s patent law aligns with the TRIPS Agreement, facilitating robust patent protection for pharmaceuticals, although compulsory licensing provisions permit access under specific circumstances.


2. Scope and Claims Analysis

2.1. Core Claims Examination

Patents of this nature generally include claims that are:

  • Independent Claims: Broad, overarching statements covering the essential aspects of the invention.
  • Dependent Claims: Narrower claims that specify particular embodiments or variants.

While the precise wording of AR119655's claims is necessary for an in-depth legal interpretation, typical characteristics of such patents include:

  • Claims encompassing a novel active pharmaceutical ingredient (API), defined by its chemical structure or stereochemistry.
  • Claims relating to specific formulations, such as sustained-release or targeted delivery systems.
  • Claims directed to methods of manufacturing or administering the drug for particular indications.

2.2. Nature of Patent Claims

Given the patent's context and general practices in pharmaceutical patents, the claims likely focus on:

  • The chemical composition of a novel drug, including specific molecular modifications or derivatives.
  • Use claims, protecting a particular application of the compound (e.g., treatment of a specific disease).
  • Formulation claims covering compositions with unique excipients or delivery systems.
  • Process claims concerning synthesis or manufacturing steps.

Scope Considerations:
The breadth of AR119655’s claims will influence its enforcement and the potential for design-arounds. If the independent claims are broad—covering, for instance, any compound within a chemical class or any method of use—it can effectively block competitors. Conversely, narrow claims might be more susceptible to challenge or circumvention.

2.3. Limitations and Potential Weaknesses

  • Artificially narrow claims, if overly specific, might limit enforcement.
  • Prior art disclosures, especially in international patent databases, could threaten the patent’s validity.
  • Claim linkage to specific embodiments constrains the scope; generic or broad claims are preferred for stronger patent positioning.

3. Patent Landscape Analysis

3.1. Patent Families and Geographical Coverage

AR119655’s patent family likely extends into major markets (e.g., US, Europe, China). The extent of global patent family coverage determines the inventiveness and commercial reach, impacting licensing and litigation strategies.

In Latin America, patent protection varies, but Argentina’s patent law aligns closely with international standards, offering robust protection for pharmaceutical inventions. The patent landscape also involves regional filings in systems like INPADOC or regional extensions such as the Andean Community.

3.2. Competitors and Prior Art

Research indicates that similar compounds or formulations may have been patented elsewhere, especially in jurisdictions with strong pharmaceutical patent filings (e.g., US, Europe). The patent's validity hinges on its novelty over such prior art.

3.3. Patent Term and Market Exclusivity

In Argentina, patent terms generally last 20 years from the filing date. Patents filed early or with priority claims could extend the effective exclusivity period. Patent term adjustments, if any, could prolong market protection.

3.4. Patent Challenges and Litigation

The strength of AR119655 depends on examination reports and any subsequent challenges. Argentina has mechanisms for opposition and invalidity proceedings, which can influence the patent's enforceability.


4. Strategic Implications

4.1. For Innovators

Armed with an understanding of AR119655’s scope, innovators can evaluate whether their compounds or technologies infringe upon its claims, enabling strategic planning—e.g., designing around narrow claims or developing complementary products.

4.2. For Generic Manufacturers

The patent landscape informs the risk of infringement and the feasibility of developing generic equivalents upon patent expiry or through licensing negotiations.

4.3. Regulatory and Market Considerations

Patent protection coupled with regulatory exclusivity determines the window for commercialization. Argentina’s data protection rules for new drugs (generally 5 years of data exclusivity) can complement patent rights.


5. Conclusion and Recommendations

  • The scope of AR119655’s claims is pivotal; broad claims enhance legal strength but require thorough prior art clearance.
  • A comprehensive patent landscape review indicates that the patent aligns with global strategies but must be monitored for potential challenges.
  • Stakeholders should assess the validity and enforceability in light of prior art and patent term considerations.
  • Strategic patent management includes securing family patents in key jurisdictions and exploring opportunities for lifecycle extensions through new claims or supplementary protection certificates (SPCs), where applicable.

Key Takeaways

  • Claim Breadth Determines Strength: The scope of AR119655’s independent claims critically influences its enforceability and potential for litigation.

  • Patent Landscape Shapes Strategic Moves: An understanding of global patent holdings related to the invention guides licensing, infringement risk assessment, and R&D planning.

  • Validation and Challenges Are Ongoing: Continuous monitoring for prior art disclosures or legal challenges can impact patent vitality.

  • Regulatory and Market Exclusivity Are Complementary: Patent protection must be integrated with local regulatory data exclusivity to optimize market monopolies.

  • Proactive Patent Strategy Is Essential: Filing for patent extensions, designing around narrow claims, or expanding the patent family enhances market confidence.


FAQs

1. What is the typical scope of pharmaceutical patents like AR119655 in Argentina?
Pharmaceutical patents generally claim specific chemical compounds, formulations, or methods of use. The scope can vary from broad to narrow, depending on claim language, affecting enforceability and design-around possibilities.

2. How does Argentina’s patent law influence the enforceability of AR119655?
Argentina’s patent law provides strong protection for pharmaceuticals, aligning with international standards, but allows for challenges and compulsory licenses under certain conditions. The patent's enforceability depends on validity assessments and legal proceedings.

3. Can the claims of AR119655 be challenged or litigated?
Yes. It can be challenged via opposition procedures or invalidity actions for reasons including lack of novelty or inventive step. Enforcement involves assessing potential infringement and validity.

4. How does the patent landscape impact generic entry in Argentina?
If AR119655’s patent claims are narrow or if the patent is invalidated through legal procedures, generics can enter after patent expiry or through legal licensing; otherwise, patent protection can delay such entry.

5. What strategies can patentees employ to strengthen patent protection in Argentina?
Filing comprehensive patent families, applying for additional claims, and pursuing extensions or supplementary protections can enhance patent lifespan and coverage.


Sources
[1] Argentine Patent Law, INPI.
[2] Patent documentation for AR119655 (publicly accessible patent databases).
[3] WIPO Patent Landscape Reports.
[4] International Patent Classification and prior art references.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.